With 3 oral presentations and 7 poster presentations, the data will highlight progress across type 2 diabetes with obesity, adult obesity, and adolescent obesity, reinforcing the potential of mazdutide to advance weight management, glycemic control, and broader metabolic health
Updates from the 2.0 framework The 2026 update confirms EASOs intention to maintain the pharmacological framework as a living evidence map, updated as new trials, outcomes, medications and formulations emerge
Understanding the science helps you make an informed decision with your prescriber
(2) Tkalcevi VI, Cuzi S, Brajsa K, Mildner B, Bokuli A, Situm K, Perovi D, Glojnari I, Parnham MJ
The amount paid by the patient depends on how the insurance plan applies those savings
Data suggests, for instance, that transient hypopigmentation occurs in around 12 percent of all patients receiving treatment using this particular laser